5,6-MeO-MiPT

Last updated
5,6-MeO-MiPT
5,6-MeO-MiPT.svg
Clinical data
Other names5,6-Dimethoxy-N-methyl-N-isopropyltryptamine
Routes of
administration 		Oral [1]
Drug class Serotonin receptor modulator
ATC code
  • None
Pharmacokinetic data
Onset of action Unknown [1]
Duration of action Unknown [1]
Identifiers
  • N-[2-(5,6-dimethoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C16H24N2O2
Molar mass 276.380 g·mol−1
3D model (JSmol)
  • CC(C)N(C)CCc2c[nH]c1cc(OC)c(OC)cc12
  • InChI=1S/C16H24N2O2/c1-11(2)18(3)7-6-12-10-17-14-9-16(20-5)15(19-4)8-13(12)14/h8-11,17H,6-7H2,1-5H3
  • Key:XXWWFLAMFUOAQG-UHFFFAOYSA-N

5,6-MeO-MiPT, also known as 5,6-dimethoxy-N-methyl-N-isopropyltryptamine, is a chemical compound of the tryptamine family. [1] It is the 5,6-dimethoxy derivative of methylisopropyltryptamine (MiPT) and is an analogue of 5-MeO-MiPT. [1] In his 1991 book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin listed the dose as greater than 75 mg orally and the duration as unknown. [1] The drug produced few to no effects at doses of up to 75 mg orally. [1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 5,6-MeO-MiPT. [1] However, the drug has been found to have abolished or profoundly reduced affinities for serotonin receptors compared to psychedelic tryptamines like MiPT and 5-MeO-MiPT. [2] 5,6-MeO-MiPT was first described in the scientific literature by David Repke and Alexander Shulgin and colleagues. [3]

Contents

See also

References

  1. 1 2 3 4 5 6 7 8 Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN   0-9630096-9-9. OCLC   38503252.
  2. ↑ McKenna DJ, Repke DB, Lo L, Peroutka SJ (March 1990). "Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes". Neuropharmacology. 29 (3): 193–198. doi:10.1016/0028-3908(90)90001-8. PMID   2139186.
  3. ↑ Repke DB, Grotjahn DB, Shulgin AT (July 1985). "Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents". J Med Chem. 28 (7): 892–896. doi:10.1021/jm00145a007. PMID   4009612.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.